Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 2.59% | 282.27 | 1.4% | $841.66m | |
| AMGN | Amgen, Inc. | 1.08% | 220.86 | 1.3% | $515.75m | |
| CELG | Celgene Corp. | 0.00% | 110.02 | 1.3% | $466.76m | |
| GILD | Gilead Sciences, Inc. | 1.98% | 65.07 | 1.0% | $400.35m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.34% | 209.80 | 1.9% | $313.89m | |
| ILMN | Illumina, Inc. | 2.53% | 305.99 | 3.5% | $311.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.92% | 344.87 | 2.6% | $267.68m | |
| EXAS | EXACT Sciences Corp. | 3.55% | 82.05 | 24.0% | $209.78m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.34% | 108.37 | 2.0% | $179.80m | |
| SGEN | Seattle Genetics, Inc. | 1.29% | 114.75 | 6.1% | $136.96m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.71% | 75.04 | 4.3% | $123.64m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.05% | 97.46 | 14.6% | $115.38m | |
| A | Agilent Technologies, Inc. | 1.95% | 78.26 | 1.6% | $101.36m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.89% | 113.05 | 5.0% | $90.40m | |
| BGNE | BeiGene Ltd. | 0.94% | 198.25 | 2.1% | $88.64m |
Company Profile
Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.